Centiva Capital »

Atara Biotherapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $353k 43k 8.13
2024-06-30 $1.2M 140k 8.50

More positions owned by Centiva Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr 7-10 Yr Trsy Bd Put Option (IEF)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr National Mun Etf (MUB)
Agnc Invt Corp Com reit (AGNC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Boeing Company Call Option (BA)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Centiva Capital

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Acadian Asset Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Renaissance Technologies
BlackRock
BlackRock
Geode Capital Management
Centiva Capital
Staley Capital Advisers

View all funds holding Atara Biotherapeutics